OBSERVE MEDICAL ASA: Mandatory notification of trades by primary insiders and close associate
Observe Medical ASA (OBSRV) · publisert 9. april 2026 kl. 13:40 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Terje Bakken via Glimt Invest AS | – | Kjøp | 182 000 | 1,08 NOK | 9. april 2026 | NO0013457952 | XOSL |
| Johan Fagerli | CFO | Kjøp | 30 000 | 1,05 NOK | 9. april 2026 | NO0013457952 | XOSL |
| Jørgen Mann | CEO | Kjøp | 50 000 | 1,1 NOK | 9. april 2026 | NO0013457952 | XOSL |
Vedlegg
- OMASA_PDMR_appendix_090426.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, 9 April 2026
Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has
been informed that Glimt Invest AS, a close associate of Terje Bakken, Chairman
of the Board and primary insider of the Company, has purchased 182,000 shares in
the Company.
Jørgen Mann, Chief Executive Officer of the Company, has purchased 50,000 shares
in the Company.
Johan Fagerli, Chief Financial Officer of the Company, has purchased 30,000
shares in the Company.
For further details, please refer to the attached notification forms.
This information is subject to the disclosure requirements pursuant to Article
19 of the EU Market Abuse Regulation and Section 5-12 of the Norwegian
Securities Trading Act.